Key Points and Future Directions from the 2024 Chinese Guidelines for Fatty Liver Disease
Open Access
- 27 March 2025
- journal article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000) , 000
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Screening strategy for non-alcoholic fatty liver diseaseClinical and Molecular Hepatology, 2023
- Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertaintiesJournal of Hepatology, 2023
- Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver diseaseJournal of Medical Economics, 2022
- Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility AnalysisGastroenterology, 2020
- Epidemiological Features of NAFLD From 1999 to 2018 in ChinaHepatology, 2020
- Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis CirrhosisJAMA Network Open, 2019
- Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patientsMedicine, 2017
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseJournal of Hepatology, 2016
- Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: A prospective cohort studyAtherosclerosis, 2015
- Severe Hypertriglyceridemia Influenced by Alcohol (SHIBA)Alcohol and Alcoholism, 2011